Archives
-
DMG-PEG2000-NH2: An Assay-Aware Linker Guide
2026-08-23
DMG-PEG2000-NH2 is an NH2-PEG derivative for rational lipid conjugation and delivery research. This guide connects its amine chemistry with particle-quality assays while separating validated product facts from hypotheses informed by sulfonamide optimization research.
-
Targeted EPO mRNA Nanotherapy for Spinal Cord Injury
2026-08-22
A 2026 Materials Today Bio study developed a mannose-modified lipid nanoparticle for preferential delivery of EPO mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, this strategy combined local EPO production with reduced neuroinflammation and ferroptosis, supporting targeted mRNA delivery as a preclinical approach to secondary spinal cord injury pathology.
-
Dextrose: Designing Better Hypoxia Assays
2026-08-22
Dextrose (D-glucose) is more than a routine nutrient: it is a controllable variable for dissecting hypoxia, glycolysis, and immune-metabolic interactions. This guide translates recent tumor-microenvironment insights into practical assay design, normalization, and troubleshooting decisions.
-
Jasplakinolide: Actin Polymerization Workflows
2026-08-21
Jasplakinolide combines membrane permeability with high-affinity F-actin binding, making it useful for live-cell imaging, in vitro filament assays, and phenotype-driven cytotoxicity studies. This practical guide covers dose design, controls, cross-domain applications, and troubleshooting for more reproducible actin experiments.
-
PUFA-PL Biosynthesis Drives Rice Blast Pathogenicity
2026-08-20
The 2024 Mycology study identifies Fad2 and Acsl4 as lipid-biosynthetic enzymes that support Magnaporthe oryzae pathogenic development through production of PUFA-containing phospholipids and ferroptosis-related lipid peroxidation. Its genetic, lipidomic, chemical-rescue, and protein-interaction evidence provides a mechanistic framework for investigating fungal cell death as a target for rice blast control.
-
SPI1/miR-616-5p Axis in NSCLC Metastasis
2026-08-20
The 2026 iScience study identifies an SPI1/miR-616-5p regulatory axis that promotes non-small cell lung cancer invasion and migration and shows that sulforaphane can inhibit this pathway. A hyaluronic acid- and folic acid-modified mesoporous silica nanoparticle formulation improves sulforaphane delivery, cellular uptake, and anti-metastatic activity in NSCLC xenograft models.
-
How to Measure Cancer Drug Responses In Vitro
2026-08-19
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent components of an in vitro cancer drug response. This framework improves interpretation of exposure timing, assay choice, and response magnitude in studies of targeted agents and anti-angiogenic therapy.
-
Protease Inhibitor Cocktail for Plant Protein Stability
2026-08-19
Protect plant-derived proteins during extraction, immunoblotting, co-immunoprecipitation, and kinase analysis with broad-spectrum, EDTA-free inhibition. This workflow-focused guide shows how to pair protein preservation with mechanistic studies of plant-virus RNA m6A regulation without confusing protease control with RNA stabilization.
-
Multiple Myeloma Cell Lines: Mutational Drivers
2026-08-18
This study provides a comprehensive whole-exome view of mutations across human multiple myeloma cell lines and connects genomic variation with altered pathways and drug response. Its main practical contribution is a framework for selecting genetically relevant models when investigating tumor progression, resistance, and candidate therapeutic targets.
-
Sodium Phosphate Dibasic for Assay Integrity
2026-08-18
Sodium phosphate dibasic is more than a routine buffer salt: its matrix effects can shape protein, enzyme, and aquatic toxicity assays. This guide connects Na2HPO4 chemistry with the sulfamonomethoxine toxicity study to show how buffer selection improves interpretation and reproducibility.
-
LKB1, Histone Lactylation, and Telomerase in Lung Cancer
2026-08-17
The reference study identifies a mechanistic link between LKB1, histone lactylation, Sp1-dependent TERT transcription, and telomere-driven senescence in lung adenocarcinoma. Its findings support combined targeting of telomerase and glycolytic metabolism as a preclinical strategy, while highlighting the need for validation across genetically diverse tumor models.
-
Recombinant Annexin V and Endothelial Thrombin Formation
2026-08-17
The 1994 reference study moved Annexin V research from synthetic phospholipid vesicles to living human endothelial-cell surfaces, quantifying both binding and functional anticoagulant activity. Its results show that recombinant Annexin V binds quiescent and stimulated HUVEC with similar affinity while inhibiting factor Xa and thrombin generation at nanomolar concentrations.
-
Dibutyryl-cAMP, Sodium Salt in Astrocyte Reprogramming
2026-08-16
Dibutyryl-cAMP, sodium salt offers a controlled way to test how cAMP signaling influences astrocyte-to-motoneuron reprogramming. This article translates the 4F reprogramming study into a causal assay framework while distinguishing pathway activation from cell-fate evidence.
-
GDC-0941: Translating PI3K/Akt Biology into Strategy
2026-08-15
GDC-0941 offers a focused way to interrogate PI3K/Akt signaling in cancer models where pathway activation, therapeutic resistance, and stem-like phenotypes intersect. This thought-leadership framework connects DRD4-driven liver cancer biology with practical assay design, biomarker development, and translational decision-making.
-
Caspase-3/7 Inhibitor I: Apoptosis Workflow
2026-08-14
Build cleaner apoptosis experiments with a selective, reversible caspase-3/7 blocker that distinguishes executioner-caspase activity from upstream signaling. This guide translates Candida krusei phase-specific findings into practical workflows for infection, cell-death, and cancer research while emphasizing controls, solubility, and orthogonal validation.